Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pro Dex (PDEX) Research & Development (2016 - 2025)

Pro Dex (PDEX) has disclosed Research & Development for 13 consecutive years, with $734000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 22.08% to $734000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 0.8% year-over-year, with the annual reading at $3.6 million for FY2025, 14.02% up from the prior year.
  • Research & Development hit $734000.0 in Q4 2025 for Pro Dex, down from $768000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.2 million in Q2 2021 to a low of $467000.0 in Q4 2022.
  • Historically, Research & Development has averaged $820750.0 across 5 years, with a median of $796500.0 in 2023.
  • Biggest five-year swings in Research & Development: tumbled 40.4% in 2022 and later skyrocketed 68.74% in 2023.
  • Year by year, Research & Development stood at $615000.0 in 2021, then decreased by 24.07% to $467000.0 in 2022, then surged by 68.74% to $788000.0 in 2023, then grew by 19.54% to $942000.0 in 2024, then fell by 22.08% to $734000.0 in 2025.
  • Business Quant data shows Research & Development for PDEX at $734000.0 in Q4 2025, $768000.0 in Q3 2025, and $905000.0 in Q2 2025.